MMWR Morb Mortal Wkly Rep. 2012 Aug 17;61(32):609-12.
Varicella surveillance practices have evolved since varicella first became nationally notifiable in 1972 (1) (Table 1). Because national surveillance data were not adequate for monitoring the impact of varicella vaccine when it became available in the United States, active surveillance for varicella was established in sentinel sites in 1995 (1,2). With declines in varicella incidence after 1 dose of varicella vaccine was added to the routine childhood vaccination schedule in 1996 (3) and a second dose was recommended in 2006 (4), the number of cases of varicella in the active surveillance sites became insufficient to monitor further impact of vaccination. CDC evaluated varicella surveillance data reported via the National Notifiable Diseases Surveillance System (NNDSS) during 2000-2010 to determine whether these data might now be adequate for monitoring vaccination impact. By 2010, a total of 39 states required reporting of varicella cases, 38 states were conducting passive case-based surveillance, and 31 met CDC's ad hoc criteria for adequate and consistent reporting. Varicella incidence in the states that met these criteria declined 79% overall, from 43 per 100,000 population in 2000 to nine in 2010. While 1 dose of varicella vaccine was recommended, incidence declined 43% during 2000-2005, and after a second dose was added to the routine childhood schedule, incidence declined 72% during 2006-2010. State varicella surveillance data reported to CDC through NNDSS are now adequate for monitoring trends in varicella incidence, but continued strengthening of the surveillance system and participation of all states is needed.
自从水痘于 1972 年首次成为全国法定报告疾病(1)(表 1)以来,水痘监测实践一直在发展。由于国家监测数据不足以监测在美国可用的水痘疫苗的影响,1995 年在哨点设立了水痘主动监测(1,2)。自 1996 年常规儿童免疫接种计划中增加一剂水痘疫苗后,水痘发病率下降(3),并于 2006 年推荐接种第二剂(4),主动监测点的水痘病例数量不足以进一步监测疫苗接种的影响。CDC 评估了通过国家法定传染病监测系统(NNDSS)报告的 2000-2010 年水痘监测数据,以确定这些数据现在是否足以监测疫苗接种的影响。到 2010 年,共有 39 个州要求报告水痘病例,38 个州正在进行基于病例的被动监测,31 个州符合 CDC 关于充分和一致报告的临时标准。符合这些标准的州的水痘发病率总体下降了 79%,从 2000 年的每 10 万人 43 例下降到 2010 年的 9 例。虽然推荐接种一剂水痘疫苗,但 2000-2005 年发病率下降了 43%,当第二剂疫苗被添加到常规儿童接种计划中后,2006-2010 年发病率下降了 72%。通过 NNDSS 向 CDC 报告的州水痘监测数据现在足以监测水痘发病率的趋势,但需要继续加强监测系统并让所有州参与。